ArticlemAbs2016

Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.

Jamie Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.